https://www.nature.com/articles/s41591-026-04522-3?error=cookies_not_supported&code=aa78ed33-c6fd-4339-941b-7c966e754993
FcRH5×CD3 bispecific antibody cevostamab in relapsed or refractory multiple myeloma: a phase 1...
Jul 22, 2026 - Fc receptor-homolog 5 (FcRH5) is a membrane protein that is ubiquitously expressed on myeloma cells. Cevostamab is a first-in-class, FcRH5×CD3 bispecific...